• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富血小板纤维蛋白(PRF)在预防药物相关性颌骨坏死(MRONJ)中的作用。

The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).

机构信息

Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.

Department of Industrial Engineering, University of Rome "Tor Vergata", 00133 Rome, Italy.

出版信息

Biomed Res Int. 2021 May 13;2021:4948139. doi: 10.1155/2021/4948139. eCollection 2021.

DOI:10.1155/2021/4948139
PMID:34095295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8140838/
Abstract

Dentoalveolar surgery is probably the major risk factor for MRONJ and for other complications following a tooth extraction, especially in patients affected by systemic diseases. The aim of this retrospective study is to evaluate whether a PRF plug inserted in the post extraction socket can prevent the onset of MRONJ. The patients were divided into two groups according to the surgical protocol that included the insertion or not of the PRF following the extraction and all the anamnestic, and clinical data were analyzed. In the control group, 5 patients developed MRONJ (19.23%) while in the study group, any case of MRONJ was reported. In the control group, patients who developed MRONJ had a CTX with less than 100 pg/mL (5 high-risk patients, Spearman's rank = .547, < .001). The use of platelet concentrates in patients with high risk of MRONJ is a user-friendly technique with an excellent cost-benefit ratio in oral surgery.

摘要

牙牙槽外科可能是 MRONJ 和拔牙后其他并发症的主要危险因素,尤其是在患有系统性疾病的患者中。本回顾性研究旨在评估拔牙窝中插入 PRF 塞是否可以预防 MRONJ 的发生。根据包括拔牙后是否插入 PRF 的手术方案,将患者分为两组,并分析所有的病史和临床数据。在对照组中,有 5 名患者(19.23%)发生了 MRONJ,而在研究组中,没有报告任何 MRONJ 病例。在对照组中,发生 MRONJ 的患者 CTX 小于 100 pg/mL(5 名高风险患者,Spearman 等级 =.547,<.001)。在 MRONJ 高风险患者中使用血小板浓缩物是一种用户友好的技术,在口腔手术中具有极佳的成本效益比。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b53/8140838/d4616ef5c4ae/BMRI2021-4948139.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b53/8140838/fc30f2afdd77/BMRI2021-4948139.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b53/8140838/d4616ef5c4ae/BMRI2021-4948139.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b53/8140838/fc30f2afdd77/BMRI2021-4948139.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b53/8140838/d4616ef5c4ae/BMRI2021-4948139.002.jpg

相似文献

1
The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).富血小板纤维蛋白(PRF)在预防药物相关性颌骨坏死(MRONJ)中的作用。
Biomed Res Int. 2021 May 13;2021:4948139. doi: 10.1155/2021/4948139. eCollection 2021.
2
Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.富血小板纤维蛋白可能降低接受口服双膦酸盐治疗的拔牙患者延迟恢复的风险:一项试验研究。
Clin Oral Investig. 2017 Sep;21(7):2165-2172. doi: 10.1007/s00784-016-2004-z. Epub 2016 Nov 11.
3
The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study.富含白细胞和血小板纤维蛋白在预防拔牙患者药物相关性颌骨坏死中的作用:一项观察性研究。
Oral Maxillofac Surg. 2024 Jun;28(2):785-793. doi: 10.1007/s10006-023-01204-z. Epub 2024 Jan 6.
4
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?一项多中心回顾性研究,探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素:原发伤口闭合和药物暂停真的能预防 MRONJ 吗?
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.
5
Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.富含血小板纤维蛋白(A-PRF)和可注射性富含血小板纤维蛋白(i-PRF)在治疗大剂量药物相关性颌骨坏死(MRONJ)中的应用:5 年随访病例报告。
Indian J Dent Res. 2020 Sep-Oct;31(5):813-818. doi: 10.4103/ijdr.IJDR_689_19.
6
Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.手术治疗、光生物调节、A-PRF 和 L-PRF 联合治疗药物相关性颌骨坏死(MRONJ):一项动物研究。
BMC Oral Health. 2022 Jun 18;22(1):241. doi: 10.1186/s12903-022-02275-2.
7
Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study.富含纤维蛋白的血小板和白细胞(L-PRF)在使用唑来膦酸的手术口腔程序中的组织修复中的疗效:病例对照研究。
Oral Maxillofac Surg. 2023 Sep;27(3):507-512. doi: 10.1007/s10006-022-01094-7. Epub 2022 Jun 24.
8
Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.应用富血小板纤维蛋白预防和治疗药物性下颌骨坏死:一项临床可行性研究。
Clin Exp Dent Res. 2023 Oct;9(5):791-798. doi: 10.1002/cre2.775. Epub 2023 Aug 21.
9
The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of Medication Related Osteonecrosis of the Jaw (MRONJ): a retrospective observational study.富白细胞-血小板纤维蛋白(L-PRF)在药物相关性颌骨坏死(MRONJ)治疗中的辅助应用:一项回顾性观察研究。
Oral Maxillofac Surg. 2024 Dec;28(4):1605-1615. doi: 10.1007/s10006-024-01291-6. Epub 2024 Sep 3.
10
Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?在富血小板纤维蛋白中添加骨形态发生蛋白2是否能改善药物相关性颌骨坏死治疗后的愈合情况?
J Oral Maxillofac Surg. 2017 Jun;75(6):1176-1184. doi: 10.1016/j.joms.2016.12.005. Epub 2016 Dec 11.

引用本文的文献

1
Comprehensive Review of Prevention and Management Strategies for Medication-related Osteonecrosis of the Jaw (MRONJ).颌骨药物性骨坏死(MRONJ)预防与管理策略的综合综述
Oral Health Prev Dent. 2025 Aug 5;23:403-417. doi: 10.3290/j.ohpd.c_2169.
2
The Use of Cyanoacrylate and Glubran in Dentistry: A Review of Clinical Applications and Outcomes.氰基丙烯酸酯和格鲁布兰在牙科中的应用:临床应用与结果综述
Materials (Basel). 2025 Jun 4;18(11):2642. doi: 10.3390/ma18112642.
3
Treatment of Medication-Related Osteonecrosis of the Jaw Without and With the Use of Advanced Platelet-Rich Fibrin: A Retrospective Clinical Study.

本文引用的文献

1
Antibacterial effects of platelet-rich fibrin produced by horizontal centrifugation.水平离心法制备富血小板纤维蛋白的抗菌作用。
Int J Oral Sci. 2020 Nov 26;12(1):32. doi: 10.1038/s41368-020-00099-w.
2
Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: An institution's experience.牙槽外科手术后预防药物相关性颌骨坏死:一家机构的经验。
J Clin Exp Dent. 2020 Aug 1;12(8):e771-e776. doi: 10.4317/jced.56837. eCollection 2020 Aug.
3
Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review.
不使用和使用高级富血小板纤维蛋白治疗药物相关性颌骨坏死:一项回顾性临床研究
J Funct Biomater. 2025 May 14;16(5):180. doi: 10.3390/jfb16050180.
4
Comparative Evaluation of Platelet-Rich Fibrin (PRF) and Concentrated Growth Factor (CGF) as Carriers for Antibiotics-In Vitro Study.富血小板纤维蛋白(PRF)和浓缩生长因子(CGF)作为抗生素载体的比较评估——体外研究
Int J Mol Sci. 2025 May 1;26(9):4303. doi: 10.3390/ijms26094303.
5
Platelet-Rich Fibrin in MRONJ Management: A Prospective Comparative Study on Its Effectiveness in Prevention and Treatment.富含血小板纤维蛋白在颌骨放射性骨坏死管理中的应用:关于其预防和治疗效果的前瞻性对照研究
Medicina (Kaunas). 2025 Mar 28;61(4):625. doi: 10.3390/medicina61040625.
6
Using platelet concentrates to treat maxillofacial tissue lesions.使用血小板浓缩物治疗颌面组织损伤。
Front Bioeng Biotechnol. 2025 Jan 7;12:1523225. doi: 10.3389/fbioe.2024.1523225. eCollection 2024.
7
Platelet-Rich Fibrin Treatment Evaluation in Patients with Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis.富含血小板纤维蛋白治疗颌骨药物相关性骨坏死和放射性骨坏死患者的疗效评估
J Clin Med. 2024 Jun 14;13(12):3473. doi: 10.3390/jcm13123473.
8
Prevalence and Factors Influencing Post-Operative Complications following Tooth Extraction: A Narrative Review.拔牙术后并发症的患病率及影响因素:一项叙述性综述
Int J Dent. 2024 May 9;2024:7712829. doi: 10.1155/2024/7712829. eCollection 2024.
9
Platelet-Rich Fibrin in Oral Surgery and Implantology: A Narrative Review.富血小板纤维蛋白在口腔外科和种植牙学中的应用:一篇叙述性综述
Transfus Med Hemother. 2022 Dec 22;50(4):348-359. doi: 10.1159/000527526. eCollection 2023 Aug.
10
Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.应用富血小板纤维蛋白预防和治疗药物性下颌骨坏死:一项临床可行性研究。
Clin Exp Dent Res. 2023 Oct;9(5):791-798. doi: 10.1002/cre2.775. Epub 2023 Aug 21.
血小板浓缩物在预防和治疗药物相关性颌骨坏死中的应用是否有效?系统评价。
J Craniomaxillofac Surg. 2020 Mar;48(3):268-285. doi: 10.1016/j.jcms.2020.01.014. Epub 2020 Feb 3.
4
Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges.欧洲颌骨药物性骨坏死特别工作组研讨会——当前挑战
Oral Dis. 2019 Oct;25(7):1815-1821. doi: 10.1111/odi.13160. Epub 2019 Aug 19.
5
The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.富血小板纤维蛋白在药物相关性颌骨坏死中的应用:一项病例系列研究。
J Stomatol Oral Maxillofac Surg. 2020 Feb;121(1):84-89. doi: 10.1016/j.jormas.2019.02.011. Epub 2019 Feb 20.
6
Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment.药物相关性颌骨坏死:预防、诊断和治疗的定义及最佳实践。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Feb;127(2):117-135. doi: 10.1016/j.oooo.2018.09.008. Epub 2018 Oct 9.
7
Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis.骨髓炎、药物相关性颌骨坏死和放射性骨坏死的组织病理学特征比较。
Int J Oral Maxillofac Surg. 2019 Jan;48(1):17-22. doi: 10.1016/j.ijom.2018.07.002. Epub 2018 Jul 24.
8
Fifteen Years of Platelet Rich Fibrin in Dentistry and Oromaxillofacial Surgery: How High is the Level of Scientific Evidence?牙科和口腔颌面外科领域应用富血小板纤维蛋白的十五年:科学证据水平有多高?
J Oral Implantol. 2018 Dec;44(6):471-492. doi: 10.1563/aaid-joi-D-17-00179. Epub 2018 Jun 5.
9
Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma.注射用富血小板纤维蛋白对成骨细胞行为和骨组织形成的影响与富血小板血浆的比较。
Platelets. 2018 Jan;29(1):48-55. doi: 10.1080/09537104.2017.1293807. Epub 2017 Mar 29.
10
Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.富血小板纤维蛋白可能降低接受口服双膦酸盐治疗的拔牙患者延迟恢复的风险:一项试验研究。
Clin Oral Investig. 2017 Sep;21(7):2165-2172. doi: 10.1007/s00784-016-2004-z. Epub 2016 Nov 11.